First insights into the utilisation of the M.BLUE <sup>®</sup> device for post-haemorrhagic hydrocephalus treatment
The M.BLUE® device appears to be a safe and effective option for treating aSAH-aH in adults. It achieved positive radiological changes with limited post-operative adjustments and demonstrated significant clinical improvements.
Authors
- Quentin Berton
- Emmanuel Chabert (ORCID: https://orcid.org/0000-0001-7893-221X)
- Marta Arrighi
- Paul Roblot (ORCID: https://orcid.org/0000-0002-0826-7004)
- Jean‐Rodolphe Vignes (ORCID: https://orcid.org/0000-0003-0647-8657)
- Guillaume Coll (ORCID: https://orcid.org/0000-0002-6117-3939)
- Alice Belmas
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Territorial de Nouvelle-Calédonie (NC)
Publication Details
- Journal
- British Journal of Neurosurgery
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1080/02688697.2025.2494555
- Primary Topic
- Cerebrospinal fluid and hydrocephalus
- Type
- article
- Field-Weighted Citation Impact
- 0.00